Hjem › Steatotisk leversykdom › Arizona
Kliniske studier for Steatotisk leversykdom i Arizona
14 studier for Steatotisk leversykdom søker deltakere på steder i Arizona.
Byer i Arizona
Offisiell studietekst (engelsk)
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Arizona Liver Health - Tucson, Tucson
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07527910Early Tracking of Childhood Health Determinants (ETCHED) Study
- NIDDK, Phoenix, Phoenix
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
1 Day – 99 Years · Alle kjønn · Oppdatert 28. sep. 2026 · NCT03481829A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Arizona Liver Health, Chandler
- The Institute for Liver Health II LLC DBA Arizona Liver Health - Peoria, Peoria
- Adobe Clinical Research, Tucson
- og 2 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
- Spectrum Research Institute, Gilbert
- The Institute for Liver Health II dba Arizona Liver Health - Peoria, Peoria
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Chandler
- Akero Clinical Study Site, Peoria
- Akero Clinical Study Site, Scottsdale
- og 4 flere
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Arizona Liver Health, Chandler
- Arizona Liver Health - Peoria, Peoria
- Adobe Clinical Research, LLC, Tucson
- og 1 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Glendale
- 89bio Clinical Study Site, Sun City
- og 2 flere
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Peoria
- 89bio Clinical Study Site, Phoenix
- og 4 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06419374A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Chandler
- GSK Investigational Site, Phoenix
- GSK Investigational Site, Tucson
- og 1 flere
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06613698Fibrosis Lessens After Metabolic Surgery
- Banner Health Center, Phoenix
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
Alder 18 til 75 · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06374875A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Chandler
- GSK Investigational Site, Tucson
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Chandler
- GSK Investigational Site, Mesa
- GSK Investigational Site, Tucson
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06920043Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- Arizona Liver Health, Chandler
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 19. mai 2026 · NCT04054310Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
- Mayo Clinic in Arizona, Scottsdale
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 30 til 70 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT04232566Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.